These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1468084)

  • 1. Third-generation cephalosporins: a review.
    Cunha BA
    Clin Ther; 1992; 14(5):616-52; discussion 615. PubMed ID: 1468084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Review of oral cephalosporins. Basis for a rational choice].
    Forti IN
    Medicina (B Aires); 1994; 54(5 Pt 1):439-58. PubMed ID: 7658980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symposium on antimicrobial therapy. IV. The cephalosporins.
    Greenfield RA
    J Okla State Med Assoc; 1993 Jan; 86(1):7-12. PubMed ID: 8426246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity, pharmacokinetics, clinical efficacy, safety and pharmacoeconomics of ceftriaxone compared with third and fourth generation cephalosporins: review.
    Bijie H; Kulpradist S; Manalaysay M; Soebandrio A
    J Chemother; 2005 Feb; 17(1):3-24. PubMed ID: 15828439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The selection and use of cephalosporins: a review.
    Klein NC; Cunha BA
    Adv Ther; 1995; 12(2):83-101. PubMed ID: 10150326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Third-generation cephalosporins: a critical evaluation.
    Barriere SL; Flaherty JF
    Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the mechanism of resistance to third-generation cephalosporins by class C beta-lactamases by using chemical complementation.
    Carter BT; Lin H; Goldberg SD; Althoff EA; Raushel J; Cornish VW
    Chembiochem; 2005 Nov; 6(11):2055-67. PubMed ID: 16250067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide.
    Drieux L; Brossier F; Sougakoff W; Jarlier V
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():90-103. PubMed ID: 18154532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of third-generation cephalosporin utilization on the occurrence of ESBL-positive Klebsiella pneumoniae strains.
    Urbánek K; Kolár M; Lovecková Y; Strojil J; Santavá L
    J Clin Pharm Ther; 2007 Aug; 32(4):403-8. PubMed ID: 17635342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cephalosporins: rationale for clinical use.
    Molavi A
    Am Fam Physician; 1991 Mar; 43(3):937-48. PubMed ID: 2000736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited-spectrum (first-generation) cephalosporins.
    Graham JM; Oshiro BT; Blanco JD
    Obstet Gynecol Clin North Am; 1992 Sep; 19(3):449-59. PubMed ID: 1436923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic and genotypic detection of ESBL mediated cephalosporin resistance in Klebsiella pneumoniae: emergence of high resistance against cefepime, the fourth generation cephalosporin.
    Grover SS; Sharma M; Chattopadhya D; Kapoor H; Pasha ST; Singh G
    J Infect; 2006 Oct; 53(4):279-88. PubMed ID: 16488476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of newer antibiotics in gastroenterology.
    Li E; Stanley SL
    Gastroenterol Clin North Am; 1992 Sep; 21(3):613-29. PubMed ID: 1516960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefepime: the next generation?
    Sanders CC
    Clin Infect Dis; 1993 Sep; 17(3):369-79. PubMed ID: 8218678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefepime: a new fourth-generation cephalosporin.
    Okamoto MP; Nakahiro RK; Chin A; Bedikian A; Gill MA
    Am J Hosp Pharm; 1994 Feb; 51(4):463-77; quiz 541-2. PubMed ID: 8017411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors associated with extended-spectrum beta-lactamase-producing organisms at a tertiary care hospital.
    Graffunder EM; Preston KE; Evans AM; Venezia RA
    J Antimicrob Chemother; 2005 Jul; 56(1):139-45. PubMed ID: 15917283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinically important beta-lactamases of gram-negative bacteria: extended-spectrum beta-lactamases (ESBL)].
    Hrabák J
    Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):103-11. PubMed ID: 17900058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of broad spectrum beta-lactamases on in vitro sensitivity of clinical isolates of Klebsiella pneumoniae to oral cephalosporins].
    Bedenić B; Singer S
    Lijec Vjesn; 2000; 122(1-2):8-13. PubMed ID: 10916350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative infection in urologic surgery.
    Ward TT
    Urology; 1985 Nov; 26(5 Suppl):6-10. PubMed ID: 3904138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.